GLYCOTOPE is a global leader in optimizing the glycosylation of biopharmaceuticals
GlycoExpress is one of the broadest platform technologies for the development and production of glycosylated proteins.
A clinical pipeline of 4 glycooptimized BioBetters and NBEs underlines GLYCOTOPE´s and its manufacturing arm GLYCOTOPE BIOTECHNOLOGY´s competence to contribute significant improvements to healthcare.
7.-9. October, 2014, Paris (France)
3.-4.- June, 2014, Lyon (France)
June 23-26, 2014, San Diego, CA
CetuGEX™ demonstrates enhanced anti-tumor activities, reduced side effects and a broader patient and indication range Berlin, Germany, April 2, 2014 – Glycotope GmbH, one of the leading companies in glycobiology, announced today the enrollment and treatment of the first …
Berlin, Germany, March 20, 2014 – Glycotope GmbH, one of the leading companies in glycobiology, expands its management team and named Henner Kollenberg as Managing Director and Chief Financial Officer (CFO) as of March 2014. Mr. Kollenberg brings more than …